Anette Sundstedt
Keine laufenden Positionen mehr
Karriereverlauf von Anette Sundstedt
Ehemalige bekannte Positionen von Anette Sundstedt
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALLIGATOR BIOSCIENCE AB | Direktor/Vorstandsmitglied | 05.07.2023 | 07.05.2024 |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Corporate Officer/Principal | 01.04.2020 | 01.03.2021 |
| ACTIVE BIOTECH AB | Direktor/Vorstandsmitglied | 01.01.2001 | 01.01.2016 |
| IDOGEN AB (PUBL) | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Anette Sundstedt
| University of Lund | Doctorate Degree |
Statistik
International
| Schweden | 6 |
Operativ
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ACTIVE BIOTECH AB | Health Technology |
| IDOGEN AB (PUBL) | Health Technology |
| ALLIGATOR BIOSCIENCE AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
- Börse
- Insiders
- Anette Sundstedt
- Erfahrung